Wu F, Song Y, Zeng H Y, Ye F, Chen B, Rong W Q, Wang L M, Niu L J, Wu J X
Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):187-191. doi: 10.3760/cma.j.cn112152-20200227-00137.
From December 2019, the new coronavirus pneumonia (COVID-19) broke out in Wuhan, Hubei, and spread rapidly to the nationwide. On January 20, 2020, the National Health Committee classified COVID-19 pneumonia as one of B class infectious diseases and treated it as class A infectious disease. During the epidemic period, the routine diagnosis and treatment of tumor patients was affected with varying degrees. In this special period, we performed the superiority of the multi-disciplinary team of diagnosis and treatment, achieved accurate diagnosis and treatment of patients with hepatobiliary malignant tumors, provided support for these patients with limited medical resources, and helped them to survive during the epidemic period.On the basis of fully understanding the new coronavirus pneumonia, the treatment strategy should be changed timely during the epidemic, and more appropriate treatment methods should be adopted to minimize the adverse effect of the epidemic on tumor treatment.
自2019年12月起，新型冠状病毒肺炎（COVID-19）在湖北武汉爆发，并迅速蔓延至全国。2020年1月20日，国家卫生健康委员会将新型冠状病毒肺炎纳入乙类传染病，并采取甲类传染病的预防、控制措施。疫情期间，肿瘤患者的常规诊疗受到不同程度的影响。在此特殊时期，我们发挥多学科诊疗团队的优势，实现了肝胆恶性肿瘤患者的精准诊疗，在医疗资源有限的情况下为这些患者提供支持，帮助他们在疫情期间生存下来。在充分了解新型冠状病毒肺炎的基础上，疫情期间应及时调整治疗策略，采取更合适的治疗方法，以尽量减少疫情对肿瘤治疗的不利影响。
